Therapeutic Potential of Cancer Vaccine Based on MHC Class I Cryptic Peptides Derived from Non-Coding Regions

Therapeutic Potential of Cancer Vaccine Based on MHC Class I Cryptic Peptides Derived from Non-Coding Regions

Blog Article

MHC class I molecules display intracellular peptides on cell surfaces to enable immune Sta-Rite U-3 Skimmer Parts surveillance under pathological conditions.The source of MHC class I antigens responsible for cancer protection is not fully understood.Here, we explored the MHC class I peptidome in mouse colon cancer cells using a proteogenomic approach.We showed that cryptic peptides derived from unconventional short open reading frames accounted for part of the MHC class I peptidome.Moreover, cancer growth was significantly prevented in mice immunized with a cocktail of synthesized cryptic peptides.

Together, our data showed that the source of cancer antigens was not limited to fragments of consensus proteins.Cryptic antigens were displayed by MHC molecules and mediated Posters anti-cancer effects, suggesting their therapeutic potential for cancer prevention.